In neurological diseases, miR‐26a‐5p could target DYRK1A to inhibits Tau phosphorylation and Aβ accumulation, which ameliorated the cognitive dysfunction, in Alzheimer's disease mice.58 This evidence concerns the gene MAPT and nervous system disorder.